GUY'S MYELOID CENTRE

State-of-the-Art diagnostics, innovative clinical trials and therapies for myeloid disorders in London. Putting the patient at the centre of what we do.

[Blood Cancer UK @bloodcancer_uk]

This #WorldCancerDay we’re launching a transformative £4 million research project to establish a clinical platform that identifies people at high risk of certain blood cancers.

How will it improve people's lives? Watch our film to find out how!

🔗 https://t.co/7ZY1t2FXdj

[Blood Cancer UK @bloodcancer_uk]

Wishing you all a very Merry Christmas,
from Blood Cancer UK.🎄❤️

[Blood Cancer UK @bloodcancer_uk]

Alyssa’s powerful story is one of determination, spirit and hope!

We aim to #DeliverHopeThisChristmas to those living with and affected by blood cancer.

Thank you to @therealgokwan for supporting our campaign. ❤️

[GUY'S MYELOID CENTRE @G_ICEMD]

Striking and important data

[Claire Harrison @harrisoncn1]

@MPNSM @RaajitRampal Manifest 2 results in full striking benefits in clinically relevant endpoints including anaemia as well as exploratory endpoints. Exciting data leaving us at the point of changing front line therapy for MF

[GUY'S MYELOID CENTRE @G_ICEMD]

👏🏻👏🏻👏🏻great contributions

[Claire Harrison @harrisoncn1]

@MPNSM @ASH2023

[Mullally Lab @MullallyLab]

Free @ 3pm today? Join Drs. Mascarenhas, Harrison, Hoffman and I for: Changing the Path of Myelofibrosis, MARRIOTT MARQUIS GRAND BALLROOM 8/9
https://t.co/iB3nrvUJvR
I'll talk on mutations, inflammation, epigenetics & JAK inhibition deficiencies @harrisoncn1 @MedscapeLIVE #MPNsm

[MPN_Hub @MPN_Hub]

Recent updates from the phase III MANIFEST-2 trial showed significant improvements in spleen volume reduction ≥35% and ≥50% reduction in Total Symptom Score in patients treated with pelabresib + ruxolitinib vs placebo.

Find out more in our article: https://t.co/PAkvWBHicZ

[Hartley Taylor @HT_Medical]

Don’t forget the two Post ASH Highlight events with top KOLs to bring you the best of ASH 2023 for the UK. LONDON 23rd and 24th Jan. STIRLING for our Scotland delegates on 31st Jan. We listened to you 😁. Registration now open

[Shahram Kordasti @KordastiL]

Join Us at ASH23

We are delighted to announce our contribution in this year’s #ASH23. Please mark your diaries for these events:

🔹 Saturday, 9th December: Our PhD student, Jing Sun, will present our innovative pipeline for analysing high-dimensional data in haematology 👇

[Shahram Kordasti @KordastiL]

And last but certainly not least, we are excited to share our joint work with Saeed Shoaie and Matteo G Della Porta , focusing on the role of the gut microbiome in myeloid malignancies.

We look forward to an enriching experience at ASH23 and invite you to join us.

[Shahram Kordasti @KordastiL]

Additionally, we are involved in four other oral presentations, in collaboration with my friend and colleague Matteo G Della Porta as below. 👇

[GUY'S MYELOID CENTRE @G_ICEMD]

A great tradition of these events .. we have amazing @MPNSM colleagues in the UK in this field and wonderful help from @HT_Medical

[Claire Harrison @harrisoncn1]

⁦@MPNVoice⁩ ⁦@HT_Medical⁩ getting ready for the fantastic back to back MPN days … Huge thanks to sponsors and attendees

[Jan Cools @CoolsJn]

"This review article will be a must-read for all my students" was one of the comments of an expert reviewer for this wonderful review article by @RogerMulet and @DelwelRuud, now available in the November issue of @Hemasphere_EHA #openaccess journal of @EHA_Hematology

[Blood Cancer UK @bloodcancer_uk]

“Let’s come together under the flag of change, join forces with groups such as Blood Cancer UK, and bring blood cancer’s profile out of the darkness and into the light...”

Read the full article by Tejal Gorasia from The Pharmaceutical Journal here: https://t.co/xyxet0BfNx

[Blood Cancer UK @bloodcancer_uk]

Join us at Walk of Light Birmingham 2024! ✨

“I took part in Walk of Light Birmingham because my husband Jack died of myelodysplastic syndrome (MDS) in April 2022.”

As the sun sets, we will walk together and shine a light on blood cancer.

Find out more: https://t.co/TUuUGfK2Kt

[Guy's and St Thomas' @GSTTnhs]

NHS England has launched a public consultation on the future location of our region’s new Children’s Cancer Principal Treatment Centre.

@EvelinaLondon is going into the consultation as the preferred provider.

Find out more and have your say⬇️
https://t.co/OkGIKAUGEY

[Guy's and St Thomas' @GSTTnhs]

Guy's and St Thomas' has celebrated completing 1⃣0⃣,0⃣0⃣0⃣operations with the @IntuitiveSurg da Vinci robot.

We installed our first da Vinci system in 2004 and now have the largest robotic surgery programme in the UK, saving thousands of lives.

https://t.co/1hM9Yt0sXV

[GUY'S MYELOID CENTRE @G_ICEMD]

#MPNSM #MPN Awareness Day #MPN Voice Sending a message to all patients and wonderful colleagues on MPN Awareness Day! From the ⁦@GSTTnhs⁩ team!

[Guy's and St Thomas' @GSTTnhs]

We'll still be there to treat patients who need urgent and emergency care, but our Emergency Department (A&E) will be very busy.

If you need non-urgent medical advice, please try and use a different service such as NHS 111, your GP or a pharmacist to get the care you need.

3/3

[GUY'S MYELOID CENTRE @G_ICEMD]

#MPNSM want to hear top data from EHA and ASCO tune in!

[VJHemOnc @VJHemOnc]

Join us for our Post-ASCO & EHA 2023 #MPN Highlights next week 📣 🩸

Feat. presentations & panel discussions on key abstracts by leading #HemOnc experts

Chaired by @harrisoncn1!

Take a look at the agenda & REGISTER 👉https://t.co/aIdUx9tg2q

#ASCO2023 #EHA2023 @DeeptiRadia